Compare HRMY & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRMY | NFE |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 324.4M |
| IPO Year | 2020 | 2019 |
| Metric | HRMY | NFE |
|---|---|---|
| Price | $37.50 | $1.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $51.33 | $7.70 |
| AVG Volume (30 Days) | 679.6K | ★ 9.3M |
| Earning Date | 02-24-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.44 | N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | $825,944,000.00 | ★ $1,768,624,000.00 |
| Revenue This Year | $23.11 | N/A |
| Revenue Next Year | $16.15 | $27.93 |
| P/E Ratio | $11.60 | ★ N/A |
| Revenue Growth | ★ 21.13 | N/A |
| 52 Week Low | $25.52 | $0.98 |
| 52 Week High | $40.93 | $16.66 |
| Indicator | HRMY | NFE |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 50.87 |
| Support Level | $35.42 | $1.04 |
| Resistance Level | $37.79 | $1.30 |
| Average True Range (ATR) | 1.04 | 0.09 |
| MACD | -0.40 | 0.01 |
| Stochastic Oscillator | 49.76 | 58.33 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.